Evaluation of Predictive CD4 Count and Clinical Reliability in Detecting Cryptococcus Neoformans at Kenyatta National Hospital


  • Mdodo. R University of Alabama at Birmingham
  • Khayeka, C.W1 Jomo Kenyatta University of Agriculture and Technology,
  • Songok, S Moi University
  • Choge, J.K University of Eastern Africa, Baraton


CD4 T cell count, Cryptococcus neoformans;, ; Cryptococcal meningitis, HIV


Cryptococcal meningitis (CM) caused by Cryptococcus neoformans is increasingly becoming a fatal fungal infection, especially among HIV/AIDS patients. This is because the HIV virus targets and destroys CD4 T cells (core cellular immune effector cells) thus causing immunosuppression. The objective of the study was to determine occurrence of CM, CD4T cells counts and assays, in patients either suspected or confirmed to have cryptococcal meningitis. The cross-sectional study design involved 51 HIV patients from KNH, during August-September 2008, sampled using Java and Applets method (2006). Results showed that CD4 T cells count among all the patients suspected to be infected with cryptococcal meningitis ranged from 0-937 cells/µL; majority had CD4 counts of ≤200 cells/µL. Since 43% of HIV patients with cryptococcal meningitis had CD4 counts of ≤143 cells/µL, a CD4 count of 143 cells/µL should be used as the lower limit below which HIV patients should be given prophylactic drugs for the disease, regardless of the prevailing clinical features seen in the affected patients

Author Biographies

Mdodo. R, University of Alabama at Birmingham

School of Public Health,C. D.C, University of Alabama at Birmingham, 1600 Clifton Rd Atlanta, GA30333,
USA/1665 University Boulevard RPHB 217 Birmingham

Khayeka, C.W1, Jomo Kenyatta University of Agriculture and Technology,

Institute of Tropical Medicine and Infectious Diseases, Jomo Kenyatta University of Agriculture and
Technology, P.O Box 20617 Nairobi-00100, Kenya

Songok, S, Moi University

Chepkoilel University College, (A Constituent of Moi University), P.O. Box 1125-30100 Eldoret

Choge, J.K, University of Eastern Africa, Baraton

School of Health Sciences, University of Eastern Africa, Baraton. P.O Box 2500, Eldoret-30100, Kenya


Amexo, M., Tolhurst, R., Barnish, G., Bates, I. (2004) Malaria misdiagnosis: effects on the poor

and vulnerable. Lancet; 238: 1896–1898.

Barnish, G., Bates, I and Iboro, J. (2004). ‘Newer drug combinations for malaria may be impractical unless diagnostic accuracy can be improved’ British Medical Journal, Vol 328:1511-1512.

Bicanic, T and Harrison, T. (2005). Cryptococcal Meningitis. British Medical Bulletin 72(1). 99-

Bii, C., Makimura, K., Abe, S., Taguchi, H., Mugasia, O., Revathi, G., Wamae, N. Kamiyas. (2007). Antifungal drug susceptibility of Cryptococcus neoformans from clinical sources in Nairobi, Kenya. Mycoses. 50 (1). pp. 25-30.

Diamond, R.D., R.K. Root and J.E. Bennet. (1972). Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro. 3. Infect. Dis. 125: 367-376.

Gilly, A., Shrikant, B., Muhindi, D et al. (2000). The changing impact of HIV/AIDS on Kenyatta National Hospital, Nairobi from 1988/89 through 1992 to 1997. AIDS 14:1625–1631.

Hakim, G., Gangaidzo, T., Heyderman, R. (2000). Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients, AIDS 14, pp. 1401-1407.

Hill, J.0. (1992). CD4+ T cells cause multinucleated giant cells to form aroundCryptococcus neoformans and confine the yeast within the primary site of infection in the respiratory tract. J. Exp. Med. 175, 1685-1695.

Hu, G., Steen, B.R., Lian, T., Sham, A.P., Tam, N., et al. (2007). Transcriptional Regulation by Protein Kinase A in Cryptococcus neoformans. PLoS Pathog 3(3):e42doi:10.1371/journal.ppat.0030042.

Huffnagle, G.B., Yates, L., Lipscomb, F. (1991). Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CD8+ T cells.J.Exp.Med.173:793-800.

Lenth, R. V. (2006). Java Applets for Power and Sample Size [Computer software]. Retrieved October, 2008, fromhttp://www.stat.uiowa.edu/~rlenth/Power.Length, 2006).

Levitz, S.M. (1992). Overview of host defenses in fungal infections. Clin.Infect. Dis. 14(Suppl.1):37-42.

Levitz, S.M., Dupont, M.P and E.H.Small. (1994). Direct activity of human T-lymphocytes and natural killer cells against C. neoformans.Infect.Immun.62:194-202.

Mitchell, T.G and J.R Perfect. (1995). Cryptococcosis in the AIDS era-100 years after the discovery of C. neoformans. Clinical Microbiological. Reviews 8:515-548.

Molyneux, M. E and Koram, K.A. (2007). “When is ‘Malaria’ Malaria? The Different Burdens of malaria Infection, Malaria Disease and Malarialike Illnesses.American Journal of Tropical Medicine and Hygiene 77(6-supl). pp. 1-5.

Murphy, J.W. (1992). Cryptococcal immunity and immunostimulation. Adv. Exp. Med. Biol. 319,225—230.

UNAIDS, (1998). AIDS Epidemic Update: December 1998. Geneva: UNAIDS.

UNAIDS, (2006). Report on Global AIDS Epidemic 2006. Geneva: UNAIDS.

Waxman, M.J., Muganda,P., Carter, J and Ongaro, N.( 2008 Dec.). The role of emergency department HIV care in resource-poor settings: lessons learned in western Kenya. Int J Emerg Med;1(4):317-320




How to Cite

R., M., C.W., K. ., S., S. ., & J.K, C. . (2012). Evaluation of Predictive CD4 Count and Clinical Reliability in Detecting Cryptococcus Neoformans at Kenyatta National Hospital. East African Journal of Pure and Applied Sciences, 2(1), Pg 25 – 31. Retrieved from http://ojs.uoeld.ac.ke/index.php/eapas/article/view/212